9 research outputs found

    The American West, 1899–1936: Prose, Poetry & Drama

    Get PDF
    This comprehensive volume presents Harriet Monroe’s (1860–1936) previously unexplored love affair with the American West, an infatuation that blossomed in three interrelated genres: prose, poetry, and drama. Known internationally as the founder and influential editor of Poetry: A Magazine of Verse, here Monroe is revealed as a prolific author with a passion for the people, scenery, and environments she encountered during western escapes from her constricted urban life in Chicago. Monroe’s western travels were transformative. Originally schooled in the literary and artistic traditions of Europe, Monroe became increasingly convinced of the fundamental importance of the American West as the muse to which American writers and artists should turn for inspiration. Her vivid impressions of the Grand Canyon, the rituals of Native Americans, and the camaraderie of outings with John Muir and the Sierra Club include writings drawn from newspaper accounts and early journal articles as well as previously unpublished archival materials. The foreword by Lindsay Atnip and the introduction by Michael R. Hill helpfully place Monroe’s genre-spanning writings within the vibrant artistic and intellectual milieu of the early twentieth century.https://digitalcommons.unl.edu/zeabook/1156/thumbnail.jp

    From Tragedy to Apocalypse in Norman Maclean’s Young Men and Fire

    Full text link

    From “Meaning” to Reality

    No full text
    This essay articulates a theory and practice of “reading toward reality” based on Polanyi’s conception of scientific discovery as proceeding from the apprehension of problems, guided by our tacit intimations of a new coherence that would resolve these problems, and a reality as the condition of such inquiry. I argue that, analogously, (good) literature poses problems of sense that refer us to our own tacit knowledge of the normative conditions of sense—conditions which underlie and sometimes contradict our conventional modes of sensemaking. Literature thus can educate us to those human realities which underlie our everyday social world and to the conditions by which we might more adequately judge and make sense of our experience.</jats:p

    Effect Of Cryotherapy On Ground Reaction Forces During A Sidestep Cut

    Full text link

    Contributors

    No full text

    Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy

    Full text link
    ImportanceAnti–vascular endothelial growth factor (VEGF) injections in eyes with nonproliferative diabetic retinopathy (NPDR) without center-involved diabetic macular edema (CI-DME) reduce development of vision-threatening complications from diabetes over at least 2 years, but whether this treatment has a longer-term benefit on visual acuity is unknown.ObjectiveTo compare the primary 4-year outcomes of visual acuity and rates of vision-threatening complications in eyes with moderate to severe NPDR treated with intravitreal aflibercept compared with sham. The primary 2-year analysis of this study has been reported.Design, Setting, and ParticipantsRandomized clinical trial conducted at 64 clinical sites in the US and Canada from January 2016 to March 2018, enrolling 328 adults (399 eyes) with moderate to severe NPDR (Early Treatment Diabetic Retinopathy Study [ETDRS] severity level 43-53) without CI-DME.InterventionsEyes were randomly assigned to 2.0 mg aflibercept (n = 200) or sham (n = 199). Eight injections were administered at defined intervals through 2 years, continuing quarterly through 4 years unless the eye improved to mild NPDR or better. Aflibercept was given in both groups to treat development of high-risk proliferative diabetic retinopathy (PDR) or CI-DME with vision loss.Main Outcomes and MeasuresDevelopment of PDR or CI-DME with vision loss (≥10 letters at 1 visit or ≥5 letters at 2 consecutive visits) and change in visual acuity (best corrected ETDRS letter score) from baseline to 4 years.ResultsAmong participants (mean age 56 years; 42.4% female; 5% Asian, 15% Black, 32% Hispanic, 45% White), the 4-year cumulative probability of developing PDR or CI-DME with vision loss was 33.9% with aflibercept vs 56.9% with sham (adjusted hazard ratio, 0.40 [97.5% CI, 0.28 to 0.57]; P &amp;amp;lt; .001). The mean (SD) change in visual acuity from baseline to 4 years was −2.7 (6.5) letters with aflibercept and −2.4 (5.8) letters with sham (adjusted mean difference, −0.5 letters [97.5% CI, −2.3 to 1.3]; P = .52). Antiplatelet Trialists’ Collaboration cardiovascular/cerebrovascular event rates were 9.9% (7 of 71) in bilateral participants, 10.9% (14 of 129) in unilateral aflibercept participants, and 7.8% (10 of 128) in unilateral sham participants.Conclusions and RelevanceAmong patients with NPDR but without CI-DME, at 4 years treatment with aflibercept vs sham, initiating aflibercept treatment only if vision-threatening complications developed, resulted in statistically significant anatomic improvement but no improvement in visual acuity. Aflibercept as a preventive strategy, as used in this trial, may not be generally warranted for patients with NPDR without CI-DME.Trial RegistrationClinicalTrials.gov Identifier: NCT02634333</jats:sec
    corecore